Member News

Catalyst for efficient drug and chemical production

A team of CSIRO scientists have made a breakthrough that could result in faster and cheaper production for the pharmaceutical, food and bulk chemistry industries. The team have developed a more efficient and simpler process that – when…

Atomic map gives malaria drug new lease on life

Researchers have for the first time mapped how one of the longest-serving malaria drugs works, opening the possibility of altering its structure to make it more effective and combat increasing malaria drug resistance. The study produced a precise…

Fellowship Brings Leading Cancer Researcher To Victoria

One of the world’s best cancer researchers working to accelerate future treatments through DNA repair has received support from the Andrews Labor Government and veski to undertake research here in Victoria. Minister for Small Business, Innovation and Trade…

British Patient Recovering Successfully Following Implant of World-First 3D Printed Titanium and Polymer Sternum

Commonwealth Scientific and Industrial Research Organization (CSIRO), the federal government agency for scientific and medical research in Australia, successfully integrated 3D printed titanium and polymer sternum implants into a British patient. In partnership withAnatomics, a Melbourne-based medical device…

BioMelbourne Network CEO on MELBOURNE 4.0 Steering Committee

The Committee for Melbourne has announced the members of the MELBOURNE 4.0 Steering Committee. The Steering Committee will drive the MELBOURNE 4.0 engagement process and ensure concrete policy initiatives are identified. Reflective of the Committee for Melbourne’s membership,…

MyGolgi – Winners of the Innovation Showcase Scholarship

Melbourne-based health technology start-up company, MyGolgi, have won the 2016 Victorian State Government supported Innovation Showcase Scholarship. MyGolgi offer an easy-to-use wearable that provides consumers with continuous feedback for injury rehabilitation and prevention. The innovative device consists of…

Biomedical Breakthroughs takes close look at our bodies at Melbourne Museum

If you’re reading this through the misery of a mid-winter flu, at least you’re better off than the poor Bendigo boy who found himself in World War I with a bullet wound in the arm, tuberculosis in the…

Melbourne based Planet innovation tops the AFR 50 Most Innovative Companies 2016 list

Every year millions of people die or become gravely ill from infectious diseases such as influenza, HIV, Chlamydia and Zika virus. Currently, 80 per cent of all tests for infectious diseases involve taking a patient sample and sending…

Big step towards cure for lifelong viral infections

New research has taken us a step closer to finding a cure for human immunodeficiency virus (HIV), as well as other infections including the glandular fever virus, which is associated with the development of lymphoma. Some infections, such…

Gordagen Receives AUD$1.3M R&D Tax Incentive

Gordagen Pharmaceuticals, a private Australian company developing biopharmaceuticals and nutraceuticals based on the medicinal properties of tocotrienols, is pleased to announce it has received a Research and Development Tax Incentive Refund of AUD$1.3 million for the 2015/2016 financial…

Stopping superbugs with a protective coat – CSIRO

Around the world 700,000 people die of drug resistant infections a year, and that figure could rise to 10 million a year by 2050. The resulting financial cost is predicted to reach $100 trillion USD. It’s a global problem…

AdAlta Ltd lists on the ASX

Melbourne-based company, and BioMelbourne Network Member,  AdAlta Limited has listed on the ASX. AdAlta is a drug discovery and development company focused on using its powerful technology platform to generate a promising new class of protein therapeutics, known…

Home

News & opinion

Member Directory

Events